Phase 4 Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older (male or female).
- People who have been diagnosed with type 2 diabetes.
- People who have been diagnosed with chronic kidney disease (CKD) with specific kidney function and protein levels in their urine, measured during the screening period (confirm with trial site for exact values).
- People whose blood sugar control measure (HbA1c) is between 6.5% and 12%.
- People who have been taking a stable dose of a specific type of blood pressure/kidney-protective medication (called an ACE inhibitor or ARB) for at least 4 weeks before the start of the trial, unless there is a medical reason not to.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with type 1 diabetes or other less common forms of diabetes.
- People with a history or medical evidence of kidney disease caused by something other than type 2 diabetes, such as lupus-related kidney disease or certain immune-related kidney conditions.
- People who have had a kidney transplant.
- People with a high potassium level in their blood (above 5.5 mmol/L) during the screening period.
- People with a severe heart failure classification (New York Heart Association Grade IV) during the screening period.
- People who have experienced a serious health event — such as a dangerous blood sugar crisis, heart attack, unstable chest pain, stroke, mini-stroke, hospitalisation for heart failure, or hospitalisation for urinary tract infection or sudden kidney injury — within the 12 weeks before screening.
- People currently taking both an ACE inhibitor and an ARB at the same time.
- People who have taken certain other blood pressure or kidney-related medications (called mineralocorticoid receptor antagonists or direct renin inhibitors) within 8 weeks before the start of the trial.
- People who have taken immune-suppressing medications or certain biological drugs within 12 weeks before screening.
- People who have taken a type of diabetes medication called an SGLT-2 inhibitor or GLP-1 receptor agonist within 8 weeks before screening, or who have previously tried an SGLT-2 inhibitor but stopped because it did not work well enough.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0571-89908582
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The average change in eGFR as measured by the total slope of eGFR from baseline to week 120
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.